TET2 and acute myeloid leukemia: Notably, the majority of loss-of function mutations in TET2 in AML originates from single-base substitutions [209] and most mutations in MDS, including mutations in DNMT3A, are C-to-T transitions at CpG, suggesting that they are due to age-related deamination of methylated cytosine [25].